Categories: News

Halper Sadeh LLP Investigates the Following Mergers; Shareholders are Encouraged to Contact the Firm – RP, CHNG, TDY, CIT

NEW YORK, Jan. 09, 2021 (GLOBE NEWSWIRE) — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

RealPage, Inc. (NASDAQ: RP) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Thoma Bravo for $88.75 in cash per share. If you are a RealPage shareholder, click here to learn more about your rights and options.

Change Healthcare Inc. (NASDAQ: CHNG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Optum, a company that is part of UnitedHealth Group. Under the merger agreement, Change Healthcare shareholders will receive $25.75 per share in cash. If you are a Change Healthcare shareholder, click here to learn more about your rights and options.

Teledyne Technologies Incorporated (NYSE: TDY) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with FLIR Systems, Inc. Under the terms of the merger agreement, FLIR shareholders will receive $28.00 per share in cash and 0.0718 shares of Teledyne common stock for each FLIR share. If you are a Teledyne shareholder, click here to learn more about your rights and options.

CIT Group Inc. (NYSE: CIT) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to First Citizens BancShares, Inc. Under the terms of the merger agreement, CIT shareholders will receive 0.0620 shares of First Citizens class A common stock for each share of CIT common stock they own. If you are a CIT Group shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com  

Staff

Recent Posts

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers…

46 minutes ago

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

12 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

15 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

15 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

15 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

15 hours ago